Application for quotation of securities - RAD

Aug 2, 2026 at 8:51 PM EDT · Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · Aug 2, 2026 at 8:51 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-rad-2

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type New announcement Date of this announcement Monday August 03, 2026 The +securities to be...

View Attachment

6ix hasn’t read this filing yet.

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

Quarterly Activities/Appendix 4C Cash Flow ReportJul 30
Change in substantial holdingJul 30
Target market determination (TMD)Jul 30
ProspectusJul 30
Notice Under Section 708AJul 28

Later from Radiopharm Theranostics

Update - Proposed issue of securities - RADAug 4
Share Purchase Plan - Now OpenAug 6
Notice of Extraordinary General Meeting and Proxy FormAug 12
RAD to meet with US FDA to align on RAD 101 Phase 3 TrialAug 16
Radiopharm Theranostics To Meet with U.S. FDA to Align on Pivotal Phase 3 Trial Design for RAD 101 in Diagnosis of Brain MetastasesAug 17

All Radiopharm Theranostics news releases

Follow Radiopharm Theranostics into a list and get an email when it puts out news.

Follow Radiopharm Theranostics